Low GROa/CXCL1 expression predicts poor outcome and promotes tumour progression in vivo and in vitro, revealing a context-dependent tumour-suppressive role in triple-negative breast cancer
This study demonstrates that low GROα/CXCL1 expression predicts poor survival and promotes tumor progression in triple-negative breast cancer, revealing a context-dependent tumor-suppressive role that warrants further investigation as a prognostic biomarker and therapeutic target.